Author(s): Michael Tarantino, Jenny Despotovic, John Grainger, et. al. EHA Library. Cooper N. Jun 14, 2019; 266488 Abstract: PF689 Session topic: 32. Platelets disorders Background Romiplostim is approved for use in patients 1 year of age or older with ITP for ≥6 months (USA) or chronic ITP (EU) who are refractory to...
Pro zobrazení tohoto obsahu je třeba být přihlášen.